Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)
-
-
-
-
-
-
-
Truist SecuritiesReinstates $25 target on Harmony Biosciences Holdings Inc. (HRMY)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)
-
-
-
-
-
-
-
Harmony Biosciences raises 2025 revenue guidance on strong WAKIX sales
-
-
-
-
-
-
-
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $50 at UBS Ahead of Topline Data
-
-
-
-
-
-
-
Goldman Sachs Resumes Harmony Biosciences Holdings Inc. (HRMY) at Neutral
-
-
-
-
-
-
-
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $48 at Mizuho
-
443,937 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

